Restrictive Cardiomyopathy

Home
Keys to Success in Medicine
Cardiovascular System
Respiratory System
Locomotor System
Endocrine and Metabolic System
Kidneys and Urinary System
Gastrointestinal Tract
Central Nervous System
Haematological System
Integumental System
Reproductive and Genital System
Recommended Reading
Forum
Links

amazon astore

ydr

aces for paces

Clinical Skills Blogspot

 

Google
Web ydr.org.uk
acesforpaces.com medicalrevision.org

 

 

Restrictive Cardiomyopathy

Title               

Ñ    Restrictive Cardiomyopathy

Definition

Ñ    Disorder characterised by:

·          Rigid non-compliant ventricles

That:

·          Resist diastolic filling

Ñ    May involve one or both ventricles more commonly the left

Pathogenesis

Causes

Internal Factors

Ñ    Idiopathic

Ñ    Endomyocardial fibrosis

Ñ    Loeffler’s endocarditis:

Hypereosinophilia and myocardial involvement

Systemic Factors

HS

Ñ    Amyloidosis

RS

Ñ    Sarcoidosis

E&M

Ñ    Haemochromatosis

Ñ    Glycogen storage disease

Pathological Process

Two types:

Ñ    Obliterative

Ñ    Non-obliterative

The primary disorder is endocardial thickening or myocardial infiltration with loss of myocytes, compensatory hypertrophy and fibrosis.

This results in:

Ñ    Diastolic dysfunction

Ñ    Systolic dysfunction may occur later

Ñ    Sinoatrial dysfunction

Ñ    Heart block of varying degrees

Ñ    Mural thrombosis and systemic emboli

Ñ    Atrioventricular valve malfunction:

Mitral or tricuspid regurgitation

Clinical Features

History

CVS

Ñ    Dyspnoea

Ñ    Orthopnoea

Ñ    Oedema

Examination

CVS

Ñ    Tachycardia

Ñ    Atrial and ventricular tachyarrhythmias

Ñ    Heart block

Ñ    Low volume pulse

Ñ    JVP elevated with rapid y descent

Ñ    Quiet praecordium

Ñ    S4:

Almost all cases

Ñ    S3 :

May occur

Ñ    Murmurs of mitral or tricuspid regurgitation

RS

Ñ    Bilateral basal crepitations (crackles)

GIT

Ñ    Hepatomegaly

Ñ    Ascites

Investigations

Imaging

Chest X-ray

Ñ    Heart size normal or small

Ñ    Enlarged in late stage

CT

Ñ    Normal pericardium

ECHO

Ñ    Normal systolic function

Ñ    Atria often dilated

Ñ    Symmetrical myocardial thickening

Ñ    Impaired ventricular filling

MRI

Ñ    Abnormal myocardial texture if myocardium is infiltrated:

Amyloid, iron

Electrophysiology

ECG

Ñ    Low voltage:

Sometimes

Ñ    Non-specific ST, T wave changes

Physiological studies

Cardiac catheterisation

Ñ    High atrial pressures with prominent y descent

Ñ    Early diastolic dip with high diastolic plateau in ventricular pressure

Ñ    Diastolic pressure is higher in the left ventricle than in the right ventricle:

Unlike constrictive pericarditis

Tissue Diagnosis

Endomyocardial Biopsy demonstrates

Ñ    Endocardial fibrosis and thickening

Ñ    Myocardial infiltration with amyloid or iron

Ñ    Chronic myocardial fibrosis

Management

Control

Drugs

Ñ    No therapy is available for most patients

Ñ    Diuretics:

Use with caution as they lower pre-load which is necessary to maintain cardiac output

Ñ    Digoxin:

Does little

Dangerous in amyloid

Ñ    Afterload reduction:

May induce profound hypotension

Ñ    Steroids:

Sarcoidosis

Hypereosinophila

Ñ    Primary amyloidosis:

Melphalan plus prednisolone with or without colchicine

Surgery

Ñ    Rarely surgical debridement may be used

Biological Agents

Phlebotomy

Ñ    Haemochromatosis

Transplantation

Ñ    Cardiac transplantation in severe cases

Ñ    Liver transplantation in familial amyloidosis

Prognosis

Ñ    Poor

Back ] Up ] Next ]

 

 

[Up]